Found: 21
Select item for more details and to access through your institution.
Validation of specificity of antibodies for immunohistochemistry: the case of ROR2.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Erratum to: Validation of specificity of antibodies for immunohistochemistry: the case of ROR2.
- Published in:
- 2016
- By:
- Publication type:
- corrected article
Author Correction: ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-15043-7
- By:
- Publication type:
- Article
The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 4, p. N.PAG, doi. 10.3390/pharmaceutics14040837
- By:
- Publication type:
- Article
The Wnt pathway: a key network in cell signalling dysregulated by viruses.
- Published in:
- Reviews in Medical Virology, 2016, v. 26, n. 5, p. 340, doi. 10.1002/rmv.1892
- By:
- Publication type:
- Article
The Wnt Gatekeeper SFRP4 Modulates EMT, Cell Migration and Downstream Wnt Signalling in Serous Ovarian Cancer Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0054362
- By:
- Publication type:
- Article
Loss of Secreted Frizzled-Related Protein 4 Correlates with an Aggressive Phenotype and Predicts Poor Outcome in Ovarian Cancer Patients.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031885
- By:
- Publication type:
- Article
ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Sex Bias in Cohorts Included in Sports Medicine Research.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall Survival.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4621, doi. 10.3390/cancers14194621
- By:
- Publication type:
- Article
Transcending Blood—Opportunities for Alternate Liquid Biopsies in Oncology.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1309, doi. 10.3390/cancers14051309
- By:
- Publication type:
- Article
ROR2 Is Epigenetically Regulated in Endometrial Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 383, doi. 10.3390/cancers13030383
- By:
- Publication type:
- Article
Recovery Efficiency of Cell-Free DNA After Bisulfite Conversion.
- Published in:
- Clinical Chemistry, 2022, v. 68, n. 9, p. 1219, doi. 10.1093/clinchem/hvac107
- By:
- Publication type:
- Article
ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-70924-z
- By:
- Publication type:
- Article
The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis.
- Published in:
- International Journal of Cancer, 2013, v. 133, n. 4, p. 779, doi. 10.1002/ijc.27984
- By:
- Publication type:
- Article
Targeting the actin/tropomyosin cytoskeleton in epithelial ovarian cancer reveals multiple mechanisms of synergy with anti-microtubule agents.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Beyond 2D cell cultures: how 3D models are changing the in vitro study of ovarian cancer and how to make the most of them.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.17603
- By:
- Publication type:
- Article
Pan-Tissue and -Cancer Analysis of ROR1 and ROR2 Transcript Variants Identify Novel Functional Significance for an Alternative Splice Variant of ROR1.
- Published in:
- Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102559
- By:
- Publication type:
- Article
A comparative analysis of 2D and 3D experimental data for the identification of the parameters of computational models.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-42486-3
- By:
- Publication type:
- Article
The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-174
- By:
- Publication type:
- Article
The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article